Saturday , April 10 2021

Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update –

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 millionClinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02Cash reserves of $5.8 million at December 31, 2020 plus funds from IPO provide funding for at least 12 months from the date of completion of …


Read the full article here

CHASE SAPPHIRE PREFERRED® 60,000 BONUS POINTS After you spend $4,000 on purchases in the first 3 months from account opening*Same page link to Offer Details — that's $750 toward travel when you redeem through Chase Ultimate Rewards®

  Of Interest

-- END RSP MOD -->